BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18930458)

  • 21. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice].
    Wu X; Lü Y; Fu K; Wang S; Zhao D; Peng H; Fan Q; Lü Y; Xin M; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Feb; 42(2):126-31. PubMed ID: 24735623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels.
    Li H; Dhanasekaran P; Alexander ET; Rader DJ; Phillips MC; Lund-Katz S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):687-93. PubMed ID: 23413428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ng CJ; Bourquard N; Hama SY; Shih D; Grijalva VR; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1368-74. PubMed ID: 17446441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
    Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
    Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.
    Kashyap VS; Santamarina-Fojo S; Brown DR; Parrott CL; Applebaum-Bowden D; Meyn S; Talley G; Paigen B; Maeda N; Brewer HB
    J Clin Invest; 1995 Sep; 96(3):1612-20. PubMed ID: 7657831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice.
    Davis HR; Hoos LM; Tetzloff G; Maguire M; Zhu LJ; Graziano MP; Altmann SW
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):841-9. PubMed ID: 17218600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
    Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
    Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative antiatherogenic effects of intravenous AAV8- and AAV2-mediated ApoA-IMilano gene transfer in hypercholesterolemic mice.
    Tian F; Wang L; Arias A; Yang M; Sharifi BG; Shah PK
    J Cardiovasc Pharmacol Ther; 2015 Jan; 20(1):66-75. PubMed ID: 24742767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice.
    Carnicer R; Navarro MA; Arbonés-Mainar JM; Acín S; Guzmán MA; Surra JC; Arnal C; de Las Heras M; Blanco-Vaca F; Osada J
    Life Sci; 2007 Jan; 80(7):638-43. PubMed ID: 17118406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE-/- mice.
    Chiba T; Ikeda M; Umegaki K; Tomita T
    Atherosclerosis; 2011 Dec; 219(2):545-51. PubMed ID: 21944698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
    Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
    Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice.
    Shnerb Ganor R; Harats D; Schiby G; Gailani D; Levkovitz H; Avivi C; Tamarin I; Shaish A; Salomon O
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):475-81. PubMed ID: 26800563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice.
    Yoshioka T; Okada T; Maeda Y; Ikeda U; Shimpo M; Nomoto T; Takeuchi K; Nonaka-Sarukawa M; Ito T; Takahashi M; Matsushita T; Mizukami H; Hanazono Y; Kume A; Ookawara S; Kawano M; Ishibashi S; Shimada K; Ozawa K
    Gene Ther; 2004 Dec; 11(24):1772-9. PubMed ID: 15496963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice.
    Hu Q; Zhang XJ; Liu CX; Wang XP; Zhang Y
    J Vasc Res; 2010; 47(1):69-79. PubMed ID: 19729954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development.
    Pan S; White TA; Witt TA; Chiriac A; Mueske CS; Simari RD
    Circ Res; 2009 Sep; 105(7):713-20, 8 p following 720. PubMed ID: 19713537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.